Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Sofia Benkhelifa"'
Autor:
Amédée Mollard, Cécile Peccate, Anne Forand, Julie Chassagne, Laura Julien, Pierre Meunier, Zoheir Guesmia, Thibaut Marais, Marc Bitoun, France Piétri-Rouxel, Sofia Benkhelifa-Ziyyat, Stéphanie Lorain
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-11 (2022)
Abstract Duchenne muscular dystrophy is a severe neuromuscular disease causing a progressive muscle wasting due to mutations in the DMD gene that lead to the absence of dystrophin protein. Adeno-associated virus (AAV)-based therapies aiming to restor
Externí odkaz:
https://doaj.org/article/5ed91629937e4299abe5d7e2bb11aa5c
Autor:
Delphine Trochet, Bernard Prudhon, Lylia Mekzine, Mégane Lemaitre, Maud Beuvin, Laura Julien, Sofia Benkhelifa-Ziyyat, Mai Thao Bui, Norma Romero, Marc Bitoun
Publikováno v:
Molecular Therapy: Nucleic Acids, Vol 27, Iss , Pp 1179-1190 (2022)
Dominant dynamin 2 (DNM2) mutations are responsible for the autosomal dominant centronuclear myopathy (AD-CNM), a rare progressive neuromuscular disorder ranging from severe neonatal to mild adult forms. We previously demonstrated that mutant-specifi
Externí odkaz:
https://doaj.org/article/3866d36cc9c9433796905ac149308456
Autor:
Feriel Azibani, Astrid Brull, Ludovic Arandel, Maud Beuvin, Isabelle Nelson, Arnaud Jollet, Esma Ziat, Bernard Prudhon, Sofia Benkhelifa-Ziyyat, Marc Bitoun, Stéphanie Lorain, Gisèle Bonne, Anne T. Bertrand
Publikováno v:
Molecular Therapy: Nucleic Acids, Vol 10, Iss , Pp 376-386 (2018)
We assessed the potential of Lmna-mRNA repair by spliceosome-mediated RNA trans-splicing as a therapeutic approach for LMNA-related congenital muscular dystrophy. This gene therapy strategy leads to reduction of mutated transcript expression for the
Externí odkaz:
https://doaj.org/article/2bc39faefe1040038e4222aaa680707a
Autor:
Delphine Trochet, Bernard Prudhon, Maud Beuvin, Cécile Peccate, Stéphanie Lorain, Laura Julien, Sofia Benkhelifa‐Ziyyat, Aymen Rabai, Kamel Mamchaoui, Arnaud Ferry, Jocelyn Laporte, Pascale Guicheney, Stéphane Vassilopoulos, Marc Bitoun
Publikováno v:
EMBO Molecular Medicine, Vol 10, Iss 2, Pp 239-253 (2017)
Abstract Rapid advances in allele‐specific silencing by RNA interference established a strategy of choice to cure dominant inherited diseases by targeting mutant alleles. We used this strategy for autosomal‐dominant centronuclear myopathy (CNM),
Externí odkaz:
https://doaj.org/article/a4426586b535417d812fa75336f2413c
Autor:
Elena Gargaun, Sestina Falcone, Guilhem Solé, Julien Durigneux, Andoni Urtizberea, Jean Marie Cuisset, Sofia Benkhelifa-Ziyyat, Laura Julien, Anne Boland, Florian Sandron, Vincent Meyer, Jean François Deleuze, David Salgado, Jean-Pierre Desvignes, Christophe Béroud, Anatole Chessel, Alexia Blesius, Martin Krahn, Nicolas Levy, France Leturcq, France Pietri-Rouxel
Publikováno v:
Biomedicines, Vol 9, Iss 2, p 219 (2021)
In skeletal muscle, long noncoding RNAs (lncRNAs) are involved in dystrophin protein stabilization but also in the regulation of myocytes proliferation and differentiation. Hence, they could represent promising therapeutic targets and/or biomarkers f
Externí odkaz:
https://doaj.org/article/968c00f1b0d148c5bfa7adb3b5474094
Autor:
Valentin Jacquier, Manon Prévot, Thierry Gostan, Rémy Bordonné, Sofia Benkhelifa-Ziyyat, Martine Barkats, Johann Soret
Publikováno v:
RNA. 28:303-319
Spinal muscular atrophy (SMA) is a devastating neurodegenerative disease caused by reduced amounts of the ubiquitously expressed Survival of Motor Neuron (SMN) protein. In agreement with its crucial role in the biogenesis of spliceosomal snRNPs, SMN-
Autor:
Delphine, Trochet, Bernard, Prudhon, Lylia, Mekzine, Mégane, Lemaitre, Maud, Beuvin, Laura, Julien, Sofia, Benkhelifa-Ziyyat, Mai Thao, Bui, Norma, Romero, Marc, Bitoun
Publikováno v:
Molecular therapy. Nucleic acids. 27
Dominant dynamin 2 (DNM2) mutations are responsible for the autosomal dominant centronuclear myopathy (AD-CNM), a rare progressive neuromuscular disorder ranging from severe neonatal to mild adult forms. We previously demonstrated that mutant-specifi
Autor:
Jeanne Lainé, Pascale Guicheney, Guy Brochier, Stéphane Vassilopoulos, Mai Thao Bui, Agathe Franck, E. Lacène, Eline Lemerle, Norma B. Romero, Marc Bitoun, Gilles Moulay, Sofia Benkhelifa-Ziyyat, Michael Trichet, Christel Gentil
Publikováno v:
Molecular Biology of the Cell
Molecular Biology of the Cell, American Society for Cell Biology, 2019, 30 (5), pp.579-590. ⟨10.1091/mbc.E18-11-0718⟩
Molecular Biology of the Cell, 2019, 30 (5), pp.579-590. ⟨10.1091/mbc.E18-11-0718⟩
Molecular Biology of the Cell, American Society for Cell Biology, 2019, 30 (5), pp.579-590. ⟨10.1091/mbc.E18-11-0718⟩
Molecular Biology of the Cell, 2019, 30 (5), pp.579-590. ⟨10.1091/mbc.E18-11-0718⟩
International audience; Clathrin plaques are stable features of the plasma membrane observed in several cell types. They are abundant in muscle, where they localize at costameres that link the contractile apparatus to the sarcolemma and connect the s
Autor:
Christel Gentil, Caroline Le Guiner, Sestina Falcone, Jean-Yves Hogrel, Cécile Peccate, Stéphanie Lorain, Sofia Benkhelifa-Ziyyat, Lydie Guigand, Marie Montus, Laurent Servais, Thomas Voit, France Piétri-Rouxel
At present, the clinically most advanced strategy to treat Duchenne muscular dystrophy (DMD) is the exon-skipping strategy. Whereas antisense oligonucleotide-based clinical trials are underway for DMD, it is essential to determine the dystrophin rest
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab0d1564d66957b55cd490f3e001e35d
https://doi.org/10.1089/hum.2016.041
https://doi.org/10.1089/hum.2016.041
Autor:
Maud Chapart, Jamila Dhiab, Mona Bensalah, Ludovic Arandel, Laura Muraine, Sofia Benkhelifa-Ziyyat, Capucine Trollet, Elisa Negroni, Anne Bigot, Vincent Mouly, Stéphane Vasseur, Gillian Butler-Browne, Alix Marhic, Gonzalo Córdova
Publikováno v:
Human Gene Therapy
Human Gene Therapy, Mary Ann Liebert, In press, ⟨10.1089/hum.2019.173⟩
Hum Gene Ther
Human Gene Therapy, In press, ⟨10.1089/hum.2019.173⟩
Human Gene Therapy, Mary Ann Liebert, 2020, 31 (3-4), pp.233-240. ⟨10.1089/hum.2019.173⟩
Human Gene Therapy, Mary Ann Liebert, In press, ⟨10.1089/hum.2019.173⟩
Hum Gene Ther
Human Gene Therapy, In press, ⟨10.1089/hum.2019.173⟩
Human Gene Therapy, Mary Ann Liebert, 2020, 31 (3-4), pp.233-240. ⟨10.1089/hum.2019.173⟩
International audience; The adeno-associated virus (AAV) vector is an efficient tool for gene delivery in skeletal muscle. AAV-based therapies show promising results for treatment of various genetic disorders, including muscular dystrophy. These dyst
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6786c03363e0ac9af5a1b805a211bbf7
https://hal.sorbonne-universite.fr/hal-02472542/document
https://hal.sorbonne-universite.fr/hal-02472542/document